Summary (tl;dr)

The United States has formally completed its withdrawal from the World Health Organization (WHO) amidst ongoing international negotiations for a critical new WHO Pandemic Agreement, creating significant shifts in global health governance.

Essential Background

The World Health Organization (WHO), a specialized agency of the United Nations, is tasked with coordinating international public health efforts and setting global health standards. The COVID-19 pandemic, originating in Wuhan, China, exposed both the vital need for global health collaboration and prompted criticism regarding the WHO's initial handling of the crisis and concerns about political influence. Citing these perceived shortcomings, then-President Donald Trump announced in January 2025 the U.S. intention to withdraw from the WHO, initiating a one-year process for the withdrawal to become effective.

The Full Story

As of January 22, 2026, the United States has officially completed its withdrawal from the World Health Organization. The U.S. Departments of Health and Human Services and State issued a joint statement, attributing the withdrawal to the WHO's alleged mishandling of the COVID-19 pandemic, its failure to implement needed reforms, and its inability to demonstrate independence from the political influence of member states. This withdrawal means the U.S. has ceased funding, recalled personnel, and is redirecting activities previously conducted with the WHO to direct bilateral engagements with other countries and organizations.

Coinciding with this development, the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement held a resumed session of its fourth meeting in Geneva from January 20-22, 2026. These crucial negotiations aim to finalize the annex for the Pathogen Access and Benefit Sharing (PABS) system, which is designed to enhance global pandemic prevention, preparedness, and response by ensuring timely and equitable sharing of pathogens and their benefits. The U.S. withdrawal, and its accompanying cessation of negotiations on the Pandemic Agreement and amendments to the International Health Regulations, presents a notable challenge to these ongoing multilateral efforts.

Why It Matters

The U.S. withdrawal holds significant implications for global public health, as the United States has historically been the WHO's largest financial contributor. Experts express concerns that this departure could undermine global efforts to respond to future disease outbreaks and impede the development of new vaccines and medicines, potentially costing the U.S. access to critical early warning data for emerging pandemics. The timing, occurring during key negotiations for a new international pandemic agreement, further complicates the establishment of a cohesive global framework for addressing future health crises. Furthermore, the U.S. pursuit of bilateral agreements for pathogen information exchange directly challenges the multilateral PABS system currently under negotiation, raising questions about the politicization of public health and the future of global health cooperation.

Geographic Location

• Washington, D.C., District of Columbia, United States (U.S. Department of Health and Human Services and U.S. Department of State announced completion of WHO withdrawal)
• Geneva, Geneva Canton, Switzerland (resumed fourth meeting of the Intergovernmental Working Group on the WHO Pandemic Agreement)
• Wuhan, Hubei Province, China (origin of the COVID-19 pandemic, cited as a reason for U.S. withdrawal)